Science Explorer Back to mapMap

Most cited papers from Ospedale San Filippo Neri

What are the most cited papers from Ospedale San Filippo Neri?

The most cited paper from Ospedale San Filippo Neri is "Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay" (Serge Cazeau, Christophe Leclercq, Thomas Lavergne et al., 2001), with 2,768 citations. Next come "Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation" (2,315) and "Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants" (1,106).

Showing 50 of 60 papers. Every paper with more than 208 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay Serge Cazeau, Christophe Leclercq, Thomas Lavergne et al. · New England Journal of Medicine Open access 22 Mar 2001 2,768
2 Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation Authors Task Force Members et al. · European Heart Journal Open access 13 Nov 2008 2,315
3 Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants Sekar Kathiresan et al. · Nature Genetics Open access123 authors 8 Feb 2009 1,106
4 State of the Art: Using Natriuretic Peptide Levels in Clinical Practice Alan S. Maisel et al. · European Journal of Heart Failure 30 Aug 2008 849
5 Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Barry J. Maron et al. · JAMA Open access 24 Jul 2007 808
6 Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention Giuseppe Patti, Giuseppe Colonna, Vincenzo Pasceri et al. · Circulation 6 Mar 2005 656
7 Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery Giuseppe Patti, Massimo Chello, Dario Candura et al. · Circulation Open access 25 Sep 2006 622
8 Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study Giancarlo Agnelli, Gualberto Gussoni, Carlo Bianchini et al. · The Lancet Oncology Sep 2009 601
9 HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices David J. Slotwiner et al. · Heart Rhythm Open access 14 May 2015 536
10 N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery Leonardo Calò, Leopoldo Bianconi, Furio Colivicchi et al. · Journal of the American College of Cardiology Open access 9 Apr 2005 512
11 The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections Massimo Sartelli et al. · World Journal of Emergency Surgery Open access 10 Jul 2017 504
12 Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing Gerardo Ansalone, Paride Giannantoni, Renato Pietro Ricci et al. · Journal of the American College of Cardiology Open access Feb 2002 491
13 Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours Pauline Vermeulen, Giampietro Gasparini, Stephen B. Fox et al. · European Journal of Cancer Aug 2002 491
14 Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention Giuseppe Patti, Vincenzo Pasceri, Giuseppe Colonna et al. · Journal of the American College of Cardiology Open access Mar 2007 484
15 Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention Vincenzo Pasceri, Giuseppe Patti, Annunziata Nusca et al. · Circulation 26 Jul 2004 466
16 European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism Christian Pristipino et al. · European Heart Journal Open access 28 Sep 2018 445
17 Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices) Giuseppe Boriani, Taya V. Glotzer, Massimo Santini et al. · European Heart Journal Open access 11 Dec 2013 429
18 2020 update of the WSES guidelines for the management of acute colonic diverticulitis in the emergency setting Massimo Sartelli et al. · World Journal of Emergency Surgery Open access 7 May 2020 408
19 Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia Pacemakers Alessandro Capucci, Massimo Santini, Luigi Padeletti et al. · Journal of the American College of Cardiology Open access 25 Oct 2005 403
20 Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? Jeroen Joost Bax, Gerardo Ansalone, Ole A. Breithardt et al. · Journal of the American College of Cardiology Open access Jul 2004 401
21 Thirty Years of Lactobacillus rhamnosus GG Lucio Capurso · Journal of Clinical Gastroenterology 9 Feb 2019 388
22 A Short‐Term, Randomized, Double‐Blind, Parallel‐Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study Jean‐Yves Le Heuzey, Gaetano Maria De Ferrari, David Radzik et al. · Journal of Cardiovascular Electrophysiology 7 Apr 2010 388
23 A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score Melina Verso, Giancarlo Agnelli, Sandro Barni et al. · Internal and Emergency Medicine 30 Apr 2012 387
24 Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events Giovanni Luca Botto, Luigi Padeletti, Massimo Santini et al. · Journal of Cardiovascular Electrophysiology Open access 31 Oct 2008 381
25 The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic Plaques Francesco Cipollone, Annalisa Iezzi, Maria Luigia Fazia et al. · Circulation Open access 12 Aug 2003 373
26 Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Robby Nieuwlaat, Alessandro Capucci, G Y H Lip et al. · European Heart Journal Open access 7 Apr 2006 372
27 Short QT syndrome: pharmacological treatment Fiorenzo Gaïta, Carla Giustetto, Francesca Bianchi et al. · Journal of the American College of Cardiology Open access Apr 2004 369
28 Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score Furio Colivicchi · European Heart Journal May 2003 366
29 High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality Alessandro Capone, Maddalena Giannella, Daniela Fortini et al. · Clinical Microbiology and Infection Open access 18 Oct 2012 366
30 Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease Mario Cottone, Anna Kohn, Marco Daperno et al. · Clinical Gastroenterology and Hepatology 9 Nov 2010 363
31 FAO/WHO Guidelines on Probiotics Lorenzo Morelli, Lucio Capurso · Journal of Clinical Gastroenterology 5 Sep 2012 344
32 Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Giampietro Gasparini, Raffaele Longo, Roberta Sarmiento et al. · The Lancet Oncology Oct 2003 336
33 ESC e-Cardiology Working Group Position Paper: Overcoming challenges in digital health implementation in cardiovascular medicine Ines Frederix et al. · European Journal of Preventive Cardiology Open access 28 Mar 2019 334
34 Polypill Strategy in Secondary Cardiovascular Prevention Jose Maria Castellano et al. · New England Journal of Medicine Open access 26 Aug 2022 326
35 A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry Gregory Y.H. Lip, Cécile Laroche, Gheorghe‐Andrei Dan et al. · EP Europace Open access 17 Dec 2013 326
36 Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes Alessandro Biffi, Antonio Pelliccia, Luisa Verdile et al. · Journal of the American College of Cardiology Open access Aug 2002 320
37 The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins Massimo Leggio, Mario Lombardi, Elisa Caldarone et al. · Hypertension Research 5 Oct 2017 317
38 Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention Germano Di Sciascio, Giuseppe Patti, Vincenzo Pasceri et al. · Journal of the American College of Cardiology Open access 3 Jul 2009 316
39 Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular Tachycardia Domenico Corrado, Hugh G Calkins, Mark S. Link et al. · Circulation Open access 7 Sep 2010 309
40 Evidence-Based Appraisal of Antireflux Fundoplication Marco Catarci, Paolo Gentileschi, Claudio Papi et al. · Annals of Surgery Open access 18 Feb 2004 309
41 Permanent Cardiac Pacing Versus Medical Treatment for the Prevention of Recurrent Vasovagal Syncope Fabrizio Ammirati, Furio Colivicchi, Massimo Santini · Circulation Open access 3 Jul 2001 303
42 Triazene compounds: Mechanism of action and related DNA repair systems Francesco Marchesi, Mario Turriziani, Grazia Tortorelli et al. · Pharmacological Research 10 Aug 2007 299
43 Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial Viviane Marie Conraads, Luigi Tavazzi, Massimo Santini et al. · European Heart Journal 28 Feb 2011 298
44 Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation Robby Nieuwlaat, Martin H. Prins, Jean Yves Le Heuzey et al. · European Heart Journal Open access 20 Mar 2008 289
45 Probiotics and health: An evidence-based review Paolo Aureli, Lucio Capurso, Anna Maria Castellazzi et al. · Pharmacological Research Open access 23 Feb 2011 281
46 Timing of Cholecystectomy for Acute Calculous Cholecystitis: A Meta-Analysis Claudio Papi, Marco Catarci, Letizia D’Ambrosio et al. · The American Journal of Gastroenterology Review 2004 266
47 Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways Marisa Granato, Celeste Rizzello, Maria Saveria Gilardini Montani et al. · The Journal of Nutritional Biochemistry 5 Jan 2017 264
48 Guidelines for procedural pain in the newborn Paola Lago, Elisabetta Garetti, Daniele Merazzi et al. · Acta Paediatrica Open access May 2009 260
49 Adverse event reporting tool to standardize the reporting and tracking of adverse events during procedural sedation: a consensus document from the World SIVA International Sedation Task Force Keira P. Mason, STEVEN M. GREEN, Q Piacevoli · British Journal of Anaesthesia Open access 12 Dec 2011 256
50 Metronomic scheduling: the future of chemotherapy? Giampietro Gasparini · The Lancet Oncology Dec 2001 255

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.